Essilor Luxottica (ESLOF) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Essilorluxottica Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.798 Hello everybody, this is Giorgio Ianella from the IR team. 00:00:03.798 -- 00:00:07.806 Thank you for joining S0 Luxottica Full Year 2025 00:00:07.806 -- 00:00:10.532 Results Management Call. 00:00:10.532 -- 00:00:15.602 The Group Chairman and CEO Francesco Milleri, the Deputy CEO Paul Dusayan, 00:00:15.602 -- 00:00:20.552 and the CFO Stefano Grassi will walk you through the business and financial highlights 00:00:20.552 -- 00:00:25.582 of last year. After their presentations, there will be a 30-minute Q&A 00:00:25.582 -- 00:00:30.891 session. If you want to make a question, please press star followed by five. 00:00:30.891 -- 00:00:36.600 We kindly ask you to limit your questions to a maximum of two. 00:00:36.600 -- 00:00:40.263 With that, I hand it over to Francesco. 00:00:40.286 -- 00:00:45.560 Welcome back, everyone, and thank you for joining us today. 00:00:45.560 -- 00:00:50.625 I am pleased to reconnect with you and to share where we stand with 00:00:50.625 -- 00:00:54.469 the execution of our new strategy, 00:00:54.469 -- 00:00:58.834 which is clearly driving the group business momentum. 00:00:58.834 -- 00:01:04.019 This is in line with our plans and I believe it will become more 00:01:04.019 -- 00:01:09.525 and more visible in the near future as the new projects, products 00:01:09.525 -- 00:01:15.609 and medical services will translate directly into numbers. 00:01:15.682 -- 00:01:17.682 2025 00:01:17.744 -- 00:01:22.830 marked a year of sharp acceleration for SC Lord Luxottica as 00:01:22.830 -- 00:01:27.835 we managed our deep transformation from a traditional optical 00:01:27.835 -- 00:01:33.020 company into a leading medtech and data-driven group. 00:01:33.020 -- 00:01:38.186 This broader scope now better defines and mak...